Compare Intuitive Surgical, Inc. (ISRG) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Wendys Co — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Wendys Co trades at $6.23 (market cap $1.19B). The key difference: Intuitive Surgical, Inc. is far larger — about 123.3× Wendys Co's market cap, and Wendys Co pays a 4.49% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Wendys Co for 77 Days on average.
| ISRG | WEN | |
|---|---|---|
Market Cap | $146.76B | $1.19B |
Volume | 2,529,814 | 5,622,905 |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $9.33 |
52-Week Low | $332.02 | $6.10 |
Typical Hold Time | 84 Days | 77 Days |
Enterprise Value | $141.54B | $4.92B |
Dividend Yield | — | 4.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
WEN trades at $6.22, up 1.8% today, but remains near multi-year lows amid bearish technical signals and fundamental pressures. The stock shows low valuation multiples (P/E 9.45, P/S 0.54) and a high ROE of 108.04%, yet faces declining net income margins (7.58% in 2025) and negative sentiment from recent franchisee bankruptcies. Earnings have consistently beaten estimates, but same-store sales declines and high debt levels ($2.66B long-term) weigh on investor confidence.
The outlook is cautious; while valuation appears cheap and dividend yield offers income, competitive pressures, shrinking sales, and leveraged balance sheet pose significant risks. Analyst consensus is 'Hold' with a $7.58 price target, suggesting limited upside without operational turnaround under new leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
